Michael Zohney

Dr. Michael Zohney

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Intelligent Surgery
Verified
Journal Article
Open access
MMMoustafa A. Mansour
Moustafa A. Mansour
MEMohamed Abdel-Fattah El-Salamoni
Mohamed Abdel-Fattah El-Salamoni
MZMichael Zohney
Michael Zohney
AEAhmed M. Elshaer
Ahmed M. Elshaer
MAMoataz Abdelwahab
Moataz Abdelwahab
AEAmr El-Samman
Amr El-Samman

11 July 2024 in Egyptian Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
SIShebl Izz-Alarab
Shebl Izz-Alarab
MZMichael Zohney
Michael Zohney
SISaied A. Issa
Saied A. Issa
AAAbdelaleem Abdelwahab
Abdelaleem Abdelwahab
AAAshraf G. Al-Abyad
Ashraf G. Al-Abyad
MAMohamed M. Aziz
Mohamed M. Aziz
Background: Large and giant pituitary adenomas (defined as tumors of maximal diameter ≥ 3–3.9 cm and ≥ 4 cm, respectively) present considerable surgical challenges regarding the extent of resection and perioperative morbidity. Endoscopic endonasal resection is considered the most effective treatment for pituitary adenomas. It allows for better visualization, maneuverability, and access to distant and lateral tumor compartments, ultimately enhancing the extent of resection. This article evaluates our initial experience with endoscopic endonasal resection of large and giant pituitary adenomas. The clinical outcomes, perioperative complications, and extent of tumor resection would be specifically addressed. Patients and methods: The primary goal of surgery was to decompress the optic pathways, and the secondary goals were to achieve maximal safe resection and hormonal control in hormone-secreting adenomas. The degree of tumor resection was classified as gross-total resection (100%), near-total resection (90–100%), subtotal resection (70–90%), and partial resection (< 70%). Results: 42 patients were included in this study. A good visual outcome achieved with 80% improvement in visual symptoms. Gross-total resection (GTR) was achieved in 19 patients (45.2%), near-total resection (NTR) was achieved in 12 patients (28.6%), subtotal resection (STR) in 6 patients (14.3%), and partial resection in the remaining 5 patients (11.9%). Subgroup analysis revealed that GTR, NTR rates were higher in large, compared to giant tumors. GTR, NTR rates of large adenomas were 59.3%, and 29.6%, compared to 20%, and 26.7% in giant adenomas respectively (p-value: 0.01428). Surgical complications were observed in 19 patients (45.2%) with CSF leakage being the most common complication (11 patients, 26.2%). Post-operative diabetes insipidus was observed in 5 patients (11.9%), major vascular injury in one case (2.4%), transient post-op 6th nerve palsy observed in 3 patients (7.1%), while two patients (4.8%) presented with post-operative paranasal sinuses infection. Conclusions: Endoscopic endonasal transsphenoidal resection of large and giant pituitary adenomas is a safe and efficient procedure. Large adenomas (3–3.9 cm) have excellent resection rates and lower complications than giant adenomas (≥ 4 cm), which may require extending our approach to achieve more tumor resection rates in the future. However, only adequate resection of these giant adenomas can be enough to achieve the main surgical goals of visual improvement, hormonal control, and decompression of surrounding structures.

1 June 2023 in QJM: An International Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AAAshraf G Al-Abyad
Ashraf G Al-Abyad
HAHesham A Abdelraheem
Hesham A Abdelraheem
HRHesham M Radwan
Hesham M Radwan
MZMichael Zohney
Michael Zohney
Low-grade gliomas are considered a therapeutic dilemma because of the heterogeneity of their clinical behavior. Patients affected by these tumors are often young and management decisions should put into consideration the potential indolent nature of these tumors and the potential long-term side effects of available therapies. to analyze the collective data from studies to define prognostic factors for overall survival in adult patients with cerebral low-grade gliomas. We prepared this systematic review with a careful following of the Cochrane Handbook for Systematic Reviews of Interventions guidelines. We conducted a literature search till December 2020 using PubMed, Scopus, Web of Science, and Cochrane Library. We performed a search for all published articles that evaluated the impact of several factors (patient’s age, KPS, neurological symptoms, histological subtype, pre-op tumor size, tumor crossing the midline, tumor enhancement, extent of resection, radiotherapy, and chemotherapy) on the overall survival (OS) and progression-free survival (PFS) of adult patients with cerebral low-grade glioma (LGG), Studies were independently assessed for risk of bias using (Cochrane Risk of Bias 2.0) for randomized controlled trials, and (Newcastle–Ottawa Scale) for retrospective cohort studies. Patient-related factors (age was found significant according to 14 of total 19 studies, KPS according to 7 of total 11 studies, and presence of seizures according to 5 of total 7 studies). Tumor-related factors (tumor subtype was significant according to 10 of total 13 studies, IDH-mutation according to 4 of total 5 studies, 1p/19q codeletion according to 5 of total 5 studies, and tumor enhancement according to 4 of total 7 studies), and treatmentrelated factors (extent of resection was significant according to 18 of total 20 studies, while timing and dose of radiation, combined chemotherapy and radiotherapy failed to show major statistical significance, with better PFS in delayed radiotherapy “till progression”, and slightly better OS in combined chemo, radiotherapy). Highly significant factors are extent of tumor resection, patient’s age, pre-op tumor volume and molecular subtype.

28 July 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
MMMoustafa A. Mansour
Moustafa A. Mansour
ARAhmed Refaat
Ahmed Refaat
AKAhmed M. Kamer-Eldawla
Ahmed M. Kamer-Eldawla
MZMichael Zohney
Michael Zohney
MEMohamed El-Batanony
Mohamed El-Batanony
HMHamdi Nabawi Mostafa
Hamdi Nabawi Mostafa
BACKGROUND: Idiopathic normal pressure hydrocephalus (iNPH) typically manifests with the classic Hakim-Adams triad of gait disturbance, cognitive impairment, and urinary incontinence. While akinetic mutism represents a rare and severe neurological presentation characterized by profound reduction in voluntary movement and speech, its association with iNPH remains underrecognized in clinical practice. This case illustrates both the diagnostic challenges and remarkable therapeutic potential when encountering this unusual manifestation of iNPH. OBSERVATIONS: A previously healthy 52-year-old female developed progressive gait instability, urinary incontinence, and cognitive decline over 6 months, followed by 3 months of akinetic mutism. Examination demonstrated characteristic features of iNPH including paratonic rigidity, magnetic gait, and frontal release signs. Neuroimaging revealed moderate ventriculomegaly with an Evans index of 0.38 and hyperdynamic CSF flow dynamics (peak velocity 7.4 cm/sec, stroke volume 95 µL). The patient exhibited dramatic clinical improvement within 1 week of ventriculoperitoneal shunt placement, with complete resolution of akinetic mutism and significant recovery of other symptoms sustained at the 6-month follow-up. LESSONS: This case underscores that akinetic mutism, while uncommon, may represent a severe but treatable manifestation of iNPH. The rapid reversal of akinetic mutism following CSF diversion highlights the importance of considering iNPH even in atypical presentations. Quantitative CSF flow analysis emerges as a valuable diagnostic tool in such challenging cases, while the striking clinical response reinforces the potential for complete functional recovery with timely intervention. https://thejns.org/doi/10.3171/CASE25257

13 November 2026 in Pituitary
Verified
Journal Article
Closed access
MZMichael Zohney
Michael Zohney
SIShebl Izz-Alarab
Shebl Izz-Alarab
ASAhmed Sammy
Ahmed Sammy
AAAbdelaleem Abdelwahab
Abdelaleem Abdelwahab
MAMohamed M. Aziz
Mohamed M. Aziz

29 September 2026 in World Neurosurgery
Verified
Journal Article
Open access
MZMichael Zohney
Michael Zohney
MEMohamed Helmy Abd Elshafouk
Mohamed Helmy Abd Elshafouk
MAMohamed M. Aziz
Mohamed M. Aziz
MIMohamed Awad Mohamed Ismail
Mohamed Awad Mohamed Ismail
KEKhaled El-Bahy
Khaled El-Bahy